RADIOMETABOLIC THERAPY WITH 131I FOR THE ABLATION OF THE THYROID REMNANT IN PATIENTS AFFECTED BY DIFFERENTIATED THYROID CANCER: COMPARISON BETWEEN THREE DIFFERENT ACTIVITIES